Multi-Drug Resistant Tuberculosis in Korea

计划入组 777 人 · 首次发布于 2006 年 6 月 21 日

HIV and Multi-Drug Resistant Tuberculosis: a Study on Clinical Outcomes

计划入组 222,128 人 · 首次发布于 2024 年 11 月 4 日

Intensifying Multi-Drug Resistant Tuberculosis Contact Tracing by Social Network Analysis

计划入组 596 人 · 首次发布于 2014 年 6 月 26 日

Streptomycin

C₂₁H₃₉N₇O₁₂ · Rx

Protionamide

C₉H₁₂N₂S · Rx

2-oxoglutarate oxygenase inhibitors (multi drug-resistant bacterial infections/cancer)

KNCV TUBERCULOSIS FOUNDATION

Nigeria

TUBERCULOSIS RESEARCH CENTRE

India

UNION MULTI CULTURES GUADELOUPEENNE

Guadeloupe

Shorter, Tailored Regimen Shows Promise for Multi-Drug Resistant Tuberculosis

India Approves Shorter, More Effective BPaLM Regimen for Drug-Resistant TB

FDA Grants Accelerated Approval to Krazati Plus Cetuximab for KRAS G12C-Mutated Colorectal Cancer